Peyrin-Biroulet L - Search Results

1

Clinical trials in ulcerative colitis: a historical perspective.

Hindryckx P, Baert F, Hart A, Magro F, Armuzzi A, Peyrin-Biroulet L; Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organisation (ECCO). Hindryckx P, et al. J Crohns Colitis. 2015 Jul;9(7):580-8. doi: 10.1093/ecco-jcc/jjv074. Epub 2015 Apr 25. J Crohns Colitis. 2015. PMID: 25913641 Review.

2

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.

Oussalah A, Danese S, Peyrin-Biroulet L. Oussalah A, et al. Curr Drug Targets. 2010 Feb;11(2):156-75. doi: 10.2174/138945010790309939. Curr Drug Targets. 2010. PMID: 20210765 Review.

3

Adalimumab in ulcerative colitis: hypes and hopes.

Fiorino G, Peyrin-Biroulet L, Repici A, Malesci A, Danese S. Fiorino G, et al. Expert Opin Biol Ther. 2011 Jan;11(1):109-16. doi: 10.1517/14712598.2011.541435. Expert Opin Biol Ther. 2011. PMID: 21133817 Review.

4

Update on Crohn's disease and ulcerative colitis.

Billioud V, Allen PB, Peyrin-Biroulet L. Billioud V, et al. Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):311-4. doi: 10.1586/egh.11.35. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21651348

5

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.

Peyrin-Biroulet L, Ferrante M, Magro F, Campbell S, Franchimont D, Fidder H, Strid H, Ardizzone S, Veereman-Wauters G, Chevaux JB, Allez M, Danese S, Sturm A; Scientific Committee of the European Crohn's and Colitis Organization. Peyrin-Biroulet L, et al. J Crohns Colitis. 2011 Oct;5(5):477-83. doi: 10.1016/j.crohns.2011.06.009. Epub 2011 Aug 3. J Crohns Colitis. 2011. PMID: 21939925

6

Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.

Williet N, Pillot C, Oussalah A, Billioud V, Chevaux JB, Bresler L, Bigard MA, Gueant JL, Peyrin-Biroulet L. Williet N, et al. Inflamm Bowel Dis. 2012 Sep;18(9):1641-6. doi: 10.1002/ibd.21932. Epub 2011 Dec 4. Inflamm Bowel Dis. 2012. PMID: 22139830

7

Implementing changes in clinical practice to improve the management of Crohn's disease.

Panaccione R, Hibi T, Peyrin-Biroulet L, Schreiber S. Panaccione R, et al. J Crohns Colitis. 2012 Feb;6 Suppl 2:S235-42. doi: 10.1016/S1873-9946(12)60503-0. J Crohns Colitis. 2012. PMID: 22463930 Review.

8

Tolerability of one hour 10 mg/kg infliximab infusions in patients with inflammatory bowel disease.

Babouri A, Buisson A, Bigard MA, Peyrin-Biroulet L. Babouri A, et al. J Crohns Colitis. 2013 Mar;7(2):129-33. doi: 10.1016/j.crohns.2012.03.007. Epub 2012 Apr 1. J Crohns Colitis. 2013. PMID: 22472090

9

5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey.

Zallot C, Billioud V, Frimat L, Faure P, Peyrin-Biroulet L; CREGG (Club de Reflexion des cabinets et Groupes d'Hépato-Gastroentérologie). Zallot C, et al. J Crohns Colitis. 2013 Aug;7(7):551-5. doi: 10.1016/j.crohns.2012.08.013. Epub 2012 Sep 21. J Crohns Colitis. 2013. PMID: 22999780

10

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.

Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L. Billioud V, et al. J Crohns Colitis. 2013 Dec;7(11):853-67. doi: 10.1016/j.crohns.2013.01.014. Epub 2013 Mar 20. J Crohns Colitis. 2013. PMID: 23523418 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,044 results

Search Page